Literature DB >> 10595940

Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

M M Verbeek1, I Otte-Höller, J van den Born, L P van den Heuvel, G David, P Wesseling, R M de Waal.   

Abstract

Heparan sulfate proteoglycans (HSPGs) have been suggested to play an important role in the formation and persistence of senile plaques and neurofibrillary tangles in dementia of the Alzheimer's type (DAT). We performed a comparative immunohistochemical analysis of the expression of the HSPGs agrin, perlecan, glypican-1, and syndecans 1-3 in the lesions of DAT brain neocortex and hippocampus. Using a panel of specific antibodies directed against the protein backbone of the various HSPG species and against the glycosaminoglycan (GAG) side-chains, we demonstrated the following. The basement membrane-associated HSPG, agrin, is widely expressed in senile plaques, neurofibrillary tangles and cerebral blood vessels, whereas the expression of the other basement membrane-associated HSPG, perlecan, is lacking in senile plaques and neurofibrillary tangles and is restricted to the cerebral vasculature. Glypican and three different syndecans, all cell membrane-associated HSPG species, are also expressed in senile plaques and neurofibrillary tangles, albeit at a lower frequency than agrin. Heparan sulfate GAG side chains are also associated with both senile plaques and neurofibrillary tangles. Our results suggest that glycosaminoglycan side chains of the HSPGs agrin, syndecan, and glypican, but not perlecan, may play an important role in the formation of both senile plaques and neurofibrillary tangles. In addition, we speculate that agrin, because it contains nine protease-inhibiting domains, may protect the protein aggregates in senile plaques and neurofibrillary tangles against extracellular proteolytic degradation, leading to the persistence of these deposits.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595940      PMCID: PMC1866925          DOI: 10.1016/S0002-9440(10)65529-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  65 in total

1.  Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma.

Authors:  J E Donahue; T M Berzin; M S Rafii; D J Glass; G D Yancopoulos; J R Fallon; E G Stopa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

2.  Ultrastructural and immunohistochemical study of degenerate neurite-bearing ghost tangles.

Authors:  K Ikeda; C Haga; S Oyanagi; S Iritani; K Kosaka
Journal:  J Neurol       Date:  1992-04       Impact factor: 4.849

3.  The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation.

Authors:  G M Castillo; W Lukito; T N Wight; A D Snow
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

4.  Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.

Authors:  G M Castillo; C Ngo; J Cummings; T N Wight; A D Snow
Journal:  J Neurochem       Date:  1997-12       Impact factor: 5.372

5.  Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation.

Authors:  M Hasegawa; R A Crowther; R Jakes; M Goedert
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

6.  The anticoagulant activation of antithrombin by heparin.

Authors:  L Jin; J P Abrahams; R Skinner; M Petitou; R N Pike; R W Carrell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Expression and characterization of human perlecan domains I and II synthesized by baculovirus-infected insect cells.

Authors:  A J Groffen; C A Buskens; K Tryggvason; J H Veerkamp; L A Monnens; L P van den Heuvel
Journal:  Eur J Biochem       Date:  1996-11-01

8.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.

Authors:  M Goedert; R Jakes; M G Spillantini; M Hasegawa; M J Smith; R A Crowther
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

9.  Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease.

Authors:  M M Verbeek; I Otte-Höller; R Veerhuis; D J Ruiter; R M De Waal
Journal:  Acta Neuropathol       Date:  1998-12       Impact factor: 17.088

10.  Primary structure and high expression of human agrin in basement membranes of adult lung and kidney.

Authors:  A J Groffen; C A Buskens; T H van Kuppevelt; J H Veerkamp; L A Monnens; L P van den Heuvel
Journal:  Eur J Biochem       Date:  1998-05-15
View more
  27 in total

1.  Investigation of the noncovalent interactions between anti-amyloid agents and amyloid beta peptides by ESI-MS.

Authors:  Eric Martineau; Janna M de Guzman; Lioudmila Rodionova; Xianqi Kong; Paul M Mayer; Ahmed M Aman
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-31       Impact factor: 3.109

Review 2.  Casting a net on dendritic spines: the extracellular matrix and its receptors.

Authors:  Lorraine E Dansie; Iryna M Ethell
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

Review 3.  Amyloid accomplices and enforcers.

Authors:  Andrei T Alexandrescu
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

Review 4.  Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.

Authors:  Manveen K Sethi; Joseph Zaia
Journal:  Anal Bioanal Chem       Date:  2016-09-06       Impact factor: 4.142

Review 5.  Role of Matricellular Proteins in Disorders of the Central Nervous System.

Authors:  A R Jayakumar; A Apeksha; M D Norenberg
Journal:  Neurochem Res       Date:  2016-11-23       Impact factor: 3.996

Review 6.  Kainic acid-mediated excitotoxicity as a model for neurodegeneration.

Authors:  Qun Wang; Sue Yu; Agnes Simonyi; Grace Y Sun; Albert Y Sun
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 7.  Tau and axonopathy in neurodegenerative disorders.

Authors:  Makoto Higuchi; Virginia M Y Lee; John Q Trojanowski
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

8.  Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice.

Authors:  Steven M Rauch; Kathy Huen; Miles C Miller; Hira Chaudry; Melissa Lau; Joshua R Sanes; Conrad E Johanson; Edward G Stopa; Robert W Burgess
Journal:  J Neuropathol Exp Neurol       Date:  2011-12       Impact factor: 3.685

9.  Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis.

Authors:  Jeffrey M Redwine; Barry Kosofsky; Russell E Jacobs; Dora Games; John F Reilly; John H Morrison; Warren G Young; Floyd E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-24       Impact factor: 11.205

Review 10.  Brain extracellular matrix in neurodegeneration.

Authors:  Dafna Bonneh-Barkay; Clayton A Wiley
Journal:  Brain Pathol       Date:  2008-07-25       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.